MCRB — Seres Therapeutics Share News
0.000.00%
Last trade - 00:00- $20.78m
- $5.18m
- $0.79m
Huawei's new smart car firm valued up to $35 bln amid advanced stake talks -sources
Changan Automobile hits near 16-mth peak on Huawei smart car tie-up
Seres Therapeutics Inc reports results for the quarter ended in September - Earnings Summary
Brief: Seres Therapeutics Q3 EPS USD -0.37
Seres Therapeutics Inc expected to post a loss of 50 cents a share - Earnings Preview
Seres Therapeutics Inc expected to post a loss of 50 cents a share - Earnings Preview
Brief: Seres Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule
Seres Therapeutics Inc reports results for the quarter ended in June - Earnings Summary
Brief: Seres Therapeutics Q2 EPS USD 0.36
Seres Therapeutics Inc expected to post earnings of 53 cents a share - Earnings Preview
Seres Therapeutics Inc expected to post earnings of 53 cents a share - Earnings Preview
Brief: Seres Therapeutics, Nestlé Health Science Announce U.S. Commercial Availability Of VOWST
Brief: Seres Therapeutics Announces Receipt Of $125 Mln Milestone From Nestlé Health Science
Brief: Seres Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Brief: Seres Therapeutics Q1 EPS USD -0.57
Brief: Seres Therapeutics Reports Ser-155 Phase 1B Cohort 1 Results Showing Successful Drug Bacteria Engraftment And Substantial Reduction In Pathogen Domination In The Gastrointestinal Microbiome
Brief: Seres Therapeutics Reports Q1 2023 Financial Results And Provides Business Updates
Brief: Seres Therapeutics And Nestlé Health Science Present Results From Ecospor Iv Phase 3 Study Of Vowst, For Prevention Of Recurrence Of C. Difficile Infection
Seres Therapeutics Inc expected to post a loss of 55 cents a share - Earnings Preview